Incremental value of late gadolinium enhancement for management of patients with hypertrophic cardiomyopathy

American Journal of Cardiology

Volumn 110, Issue 8, 2012, Pages 1207-1212

  Greulich, Simon ^a   Schumm, Julia ^a   Grün, Stefan ^a   Bruder, Oliver ^b   Sechtem, Udo ^a   Mahrholdt, Heiko ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b ELISABETH KRANKENHAUS ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DIAGNOSTIC PROCEDURE; FAINTNESS; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPERTROPHIC SCAR; LATE GADOLINIUM ENHANCEMENT; MYOCARDIAL SCARRING; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SUDDEN DEATH;

CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84866729884     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.05.064     Document Type: Review

References (28)

1. C.R. Cannan, G.S. Reeder, K.R. Bailey, L.J. Melton III, B.J. Gersh Natural history of hypertrophic cardiomyopathy A population-based study, 1976 through 1990 Circulation 92 1995 2488 2495
2. B.J. Maron, I. Olivotto, P. Spirito, S.A. Casey, P. Bellone, T.E. Gohman, K.J. Graham, D.A. Burton, F. Cecchi Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population Circulation 102 2000 858 864
3. B.J. Maron Sudden death in young athletes N Engl J Med 349 2003 1064 1075
4. B.J. Maron, W.J. McKenna, G.K. Danielson, L.J. Kappenberger, H.J. Kuhn, C.E. Seidman, P.M. Shah, W.H. Spencer III, P. Spirito, F.J. Ten Cate, E.D. Wigle American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Eur Heart J 24 2003 1965 1991
5. K.M. Harris, P. Spirito, M.S. Maron, A.G. Zenovich, F. Formisano, J.R. Lesser, S. Mackey-Bojack, W.J. Manning, J.E. Udelson, B.J. Maron Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy Circulation 114 2006 216 225
6. B.J. Maron, P. Spirito Implications of left ventricular remodeling in hypertrophic cardiomyopathy Am J Cardiol 81 1998 1339 1344
7. P. Melacini, C. Basso, A. Angelini, C. Calore, F. Bobbo, B. Tokajuk, N. Bellini, G. Smaniotto, M. Zucchetto, S. Iliceto, G. Thiene, B.J. Maron Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy Eur Heart J 31 2010 2111 2123
8. A. Wagner, H. Mahrholdt, T.A. Holly, M.D. Elliott, M. Regenfus, M. Parker, F.J. Klocke, R.O. Bonow, R.J. Kim, R.M. Judd Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study Lancet 361 2003 374 379
9. D. Bello, A. Einhorn, R. Kaushal, S. Kenchaiah, A. Raney, D. Fieno, J. Narula, J. Goldberger, K. Shivkumar, H. Subacius, A. Kadish Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease Magn Reson Imaging 29 2011 50 56
10. K.C. Wu, R.G. Weiss, D.R. Thiemann, K. Kitagawa, A. Schmidt, D. Dalal, S. Lai, D.A. Bluemke, G. Gerstenblith, E. Marbán, G.F. Tomaselli, J.A. Lima Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy J Am Coll Cardiol 51 2008 2414 2421
11. P.M. Elliott, S. Sharma, A. Varnava, J. Poloniecki, E. Rowland, W.J. McKenna Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 33 1999 1596 1601
12. A.M. Varnava, P.M. Elliott, N. Mahon, M.J. Davies, W.J. McKenna Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy Am J Cardiol 88 2001 275 279
13. B.J. Maron, W.K. Shen, M.S. Link, A.E. Epstein, A.K. Almquist, J.P. Daubert, G.H. Bardy, S. Favale, R.F. Rea, G. Boriani, N.A. Estes III, P. Spirito Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy N Engl J Med 342 2000 365 373
14. L. Choudhury, H. Mahrholdt, A. Wagner, K.M. Choi, M.D. Elliott, F.J. Klocke, R.O. Bonow, R.M. Judd, R.J. Kim Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy J Am Coll Cardiol 40 2002 2156 2164
15. O. Bruder, A. Wagner, C.J. Jensen, S. Schneider, P. Ong, E.M. Kispert, K. Nassenstein, T. Schlosser, G.V. Sabin, U. Sechtem, H. Mahrholdt Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 875 887
16. J.C. Moon, W.J. McKenna, J.A. McCrohon, P.M. Elliott, G.C. Smith, D.J. Pennell Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 2003 1561 1567
17. A.S. Adabag, B.J. Maron, E. Appelbaum, C.J. Harrigan, J.L. Buros, C.M. Gibson, J.R. Lesser, C.A. Hanna, J.E. Udelson, W.J. Manning, M.S. Maron Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance J Am Coll Cardiol 51 2008 1369 1374
18. B.J. Maron, P. Spirito, W.K. Shen, T.S. Haas, F. Formisano, M.S. Link Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy JAMA 298 2007 405 412 (erratum JAMA 2007;298:1516)
19. I. Jayatilleke, A. Doolan, J. Ingles, M. McGuire, V. Booth, D.R. Richmond, C. Semsarian Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy Am J Cardiol 93 2004 1192 1194
20. B.J. Gersh, B.J. Maron, R.O. Bonow, J.A. Dearani, M.A. Fifer, M.S. Link, S.S. Naidu, R.A. Nishimura, S.R. Ommen, H. Rakowski, C.E. Seidman, J.A. Towbin, J.E. Udelson, C.W. Yancy 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 124 2011 2761 2796
21. C. Rickers, N.M. Wilke, M. Jerosch-Herold, S.A. Casey, P. Panse, N. Panse, J. Weil, A.G. Zenovich, B.J. Maron Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy Circulation 112 2005 855 861
22. P.M. Elliott, J. Poloniecki, S. Dickie, S. Sharma, L. Monserrat, A. Varnava, N.G. Mahon, W.J. McKenna Sudden death in hypertrophic cardiomyopathy: identification of high risk patients J Am Coll Cardiol 36 2000 2212 2218
23. P. Elliott, J. Gimeno, M. Tomé, W. McKenna Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy Eur Heart J 27 2006 3073
24. M.S. Maron, E. Appelbaum, C.J. Harrigan, J. Buros, C.M. Gibson, C. Hanna, J.R. Lesser, J.E. Udelson, W.J. Manning, B.J. Maron Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy Circ Heart Fail 1 2008 184 191
25. R. O'Hanlon, A. Grasso, M. Roughton, J.C. Moon, S. Clark, R. Wage, J. Webb, M. Kulkarni, D. Dawson, L. Sulaibeekh, B. Chandrasekaran, C. Bucciarelli-Ducci, F. Pasquale, M.R. Cowie, W.J. McKenna, M.N. Sheppard, P.M. Elliott, D.J. Pennell, S.K. Prasad Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 867 874
26. R. Rubinshtein, J.F. Glockner, S.R. Ommen, P.A. Araoz, M.J. Ackerman, P. Sorajja, J.M. Bos, A.J. Tajik, U.S. Valeti, R.A. Nishimura, B.J. Gersh Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy Circ Heart Fail 3 2010 51 58
27. J.J. Green, J.S. Berger, C.M. Kramer, M. Salerno Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy JACC Cardiovasc Imaging 5 2012 370 377
28. B.J. Maron Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy Circ J 74 2010 2271 2282